The criteria include four factors: tumor diameter > 5.5 cm, carcinoembryonic antigen (CEA) > 80 μg/L, less than a two-year interval between primary resection and LT, and progressive disease at the time of LT. Here, CEACAM5 is linked to neoplasm.